Follow
Hiangkiat (Jason) Tan
Hiangkiat (Jason) Tan
HealthCore
Verified email at healthcore.com
Title
Cited by
Cited by
Year
Doctor–patient communication, health-related beliefs, and adherence in glaucoma: results from the glaucoma adherence and persistency study
DS Friedman, SR Hahn, L Gelb, J Tan, SN Shah, EE Kim, TJ Zimmerman, ...
Ophthalmology 115 (8), 1320-1327. e3, 2008
3632008
Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS)
DS Friedman, HA Quigley, L Gelb, J Tan, J Margolis, SN Shah, EE Kim, ...
Investigative ophthalmology & visual science 48 (11), 5052-5057, 2007
3282007
Impact of adherence to disease-modifying therapies on clinical and economic outcomes among patients with multiple sclerosis
H Tan, Q Cai, S Agarwal, JJ Stephenson, S Kamat
Advances in therapy 28, 51-61, 2011
2632011
Proton pump inhibitor utilization patterns in infants
JJ Barron, H Tan, J Spalding, AW Bakst, J Singer
Journal of pediatric gastroenterology and nutrition 45 (4), 421-427, 2007
2622007
Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2× 2 factorial randomized controlled trial comparing insulin pump with multiple daily …
SA Little, L Leelarathna, E Walkinshaw, HK Tan, O Chapple, ...
Diabetes care 37 (8), 2114-2122, 2014
2442014
Comparison of insulin degludec/insulin aspart and biphasic insulin aspart 30 in uncontrolled, insulin-treated type 2 diabetes: a phase 3a, randomized, treat-to-target trial
GR Fulcher, JS Christiansen, G Bantwal, M Polaszewska-Muszynska, ...
Diabetes Care 37 (8), 2084-2090, 2014
1432014
The impact of ocular adverse effects in patients treated with topical prostaglandin analogs: changes in prescription patterns and patient persistence
TJ Zimmerman, SR Hahn, L Gelb, H Tan, EE Kim
Journal of ocular pharmacology and therapeutics 25 (2), 145-152, 2009
1102009
Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population
JA Doshi, Q Cai, JL Buono, WM Spalding, P Sarocco, H Tan, ...
Journal of Managed Care Pharmacy 20 (4), 382-390, 2014
942014
Incidence of osteonecrosis of the jaw among users of bisphosphonates with selected cancers or osteoporosis
P Tennis, KJ Rothman, RL Bohn, H Tan, A Zavras, C Laskarides, ...
Pharmacoepidemiology and drug safety 21 (8), 810-817, 2012
912012
Impact of asthma controller medications on clinical, economic, and patient-reported outcomes
H Tan, C Sarawate, J Singer, K Elward, RI Cohen, BA Smart, MF Busk, ...
Mayo Clinic Proceedings 84 (8), 675-684, 2009
812009
Impact and factors associated with nighttime and early morning symptoms among patients with chronic obstructive pulmonary disease
JJ Stephenson, Q Cai, M Mocarski, H Tan, JA Doshi, SD Sullivan
International journal of chronic obstructive pulmonary disease, 577-586, 2015
802015
Clinical and economic impact of a specialty care management program among patients with multiple sclerosis: a cohort study
H Tan, J Yu, D Tabby, A Devries, J Singer
Multiple Sclerosis Journal 16 (8), 956-963, 2010
762010
Diabetes technology and the human factor
A Liberman, B Buckingham
Diabetes technology & therapeutics 18 (S1), S-101-S-111, 2016
722016
Comparative effectiveness of colony-stimulating factors for febrile neutropenia: a retrospective study
H Tan, K Tomic, D Hurley, G Daniel, R Barron, J Malin
Current medical research and opinion 27 (1), 79-86, 2011
712011
Designing safe drug names
BL Lambert, SJ Lin, HK Tan
Drug Safety 28, 495-512, 2005
712005
Latanoprost-induced prostaglandin-associated periorbitopathy
J Tan, S Berke
Optometry and Vision Science 90 (9), e245-e247, 2013
482013
Exacerbations among chronic bronchitis patients treated with maintenance medications from a US managed care population: an administrative claims data analysis
A AbuDagga, SX Sun, H Tan, CT Solem
International Journal of Chronic Obstructive Pulmonary Disease, 175-185, 2013
462013
Comparison of claims vs patient-reported adherence measures and associated outcomes among patients with nonvalvular atrial fibrillation using oral anticoagulant therapy
JJ Stephenson, MU Shinde, WJ Kwong, AC Fu, H Tan, WS Weintraub
Patient Preference and Adherence, 105-117, 2018
402018
Characteristics affecting oral anticoagulant therapy choice among patients with non-valvular atrial fibrillation: a retrospective claims analysis
A AbuDagga, JJ Stephenson, AC Fu, WJ Kwong, H Tan, WS Weintraub
BMC health services research 14, 1-9, 2014
392014
Healthcare costs among patients with chronic constipation: a retrospective claims analysis in a commercially insured population
Q Cai, JL Buono, WM Spalding, P Sarocco, H Tan, JJ Stephenson, ...
Journal of Medical Economics 17 (2), 148-158, 2014
372014
The system can't perform the operation now. Try again later.
Articles 1–20